{ "Investigational Scan for Prostate Cancer After Focal Therapy", "This study is testing a new type of scan called flotufolastat F 18 PET/CT. This scan helps doctors see if prostate cancer has returned or if any cancer cells are still present after you've had focal therapy (like laser, cryotherapy, or HIFU). Flotufolastat F 18 is a special tracer that attaches to prostate cancer cells, making them visible on the scan. The study aims to see how accurate this scan is compared to a prostate biopsy in finding cancer. You may be able to join if you are a man aged 18-90, have a history of prostate cancer, and had focal therapy between 6 and 36 months ago. The study plans to enroll 81 participants, but its current status is unclear.", "design": "This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 81 men.", "commitments": "You will receive an intravenous (IV) injection of flotufolastat F-18, followed by a whole-body PET/CT scan. You will also have a PET/CT/ultrasound fusion biopsy within 3 months.", "compensation": "Not stated in the trial record.", "follow_up": "You will be followed up at 1 month after your biopsy and then every 12 months for up to 10 years.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.